Your browser doesn't support javascript.
loading
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial.
Smyth, Elizabeth; Cozens, Kelly; Griffiths, Daniel; Clark, Kathryn L; Ewings, Sean; Petty, Russell; Underwood, Tim; Fitzgerald, Rebecca C; Tanner, James; Giger, Olivier; Anand, Shubha; Griffiths, Gareth.
Afiliação
  • Smyth E; Cambridge University Hospitals National Health Service Foundation Trust, Hill's Road, Cambridge, UK.
  • Cozens K; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Griffiths D; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. D.P.Griffiths@soton.ac.uk.
  • Clark KL; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Ewings S; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Petty R; University of Dundee, Dundee, UK.
  • Underwood T; School of Cancer Sciences, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Fitzgerald RC; University of Cambridge, Cambridge, UK.
  • Tanner J; Cambridge University Hospitals National Health Service Foundation Trust, Hill's Road, Cambridge, UK.
  • Giger O; Cambridge University Hospitals National Health Service Foundation Trust, Hill's Road, Cambridge, UK.
  • Anand S; University of Cambridge, Cambridge, UK.
  • Griffiths G; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
BMC Cancer ; 22(1): 946, 2022 Sep 01.
Article em En | MEDLINE | ID: mdl-36050653

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Nivolumabe Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Nivolumabe Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido